
CON
Concentra Group Holdings Parent Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
20.010
Open
19.740
VWAP
19.69
Vol
698.70K
Mkt Cap
2.52B
Low
19.610
Amount
13.76M
EV/EBITDA(TTM)
11.01
Total Shares
128.17M
EV
4.13B
EV/OCF(TTM)
17.07
P/S(TTM)
0.95
Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. It delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care, to more than 50,000 patients each day, on average, from about 620 occupational health centers in 41 states and 160 onsite health clinics at employer worksites in 36 states. Its Occupational Health Centers segment encompasses the services it delivers at its occupational health center facilities across the United States. Its Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services. Its Other Businesses segment comprises several complementary services to its core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration.
Show More
4 Analyst Rating

39.88% Upside
Wall Street analysts forecast CON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CON is 27.50 USD with a low forecast of 25.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy

39.88% Upside
Current: 19.660

Low
25.00
Averages
27.50
High
30.00

39.88% Upside
Current: 19.660

Low
25.00
Averages
27.50
High
30.00
JP Morgan
Lisa Gill
Buy
Maintains
$29 → $30
2025-03-19
Reason
JP Morgan
Lisa Gill
Price Target
$29 → $30
2025-03-19
Maintains
Buy
Reason
JPMorgan analyst Lisa Gill raised the firm's price target on Concentra to $30 from $29 and keeps an Overweight rating on the shares. Following Q4 earnings, the firm is updating its estimates, noting that for 2025 it increased its revenue estimate to $2.115B and its adjusted EBITDA estimate to $420M while also increasing its 2026 revenue and adjusted EBITDA estimates.
RBC Capital
Ben Hendrix
Buy
Reiterates
$30
2025-01-23
Reason
RBC Capital
Ben Hendrix
Price Target
$30
2025-01-23
Reiterates
Buy
Reason
B of A Securities
Joanna Gajuk
Strong Buy
Maintains
$24 → $25
2025-01-23
Reason
B of A Securities
Joanna Gajuk
Price Target
$24 → $25
2025-01-23
Maintains
Strong Buy
Reason
BofA raised the firm's price target on Concentra to $25 from $24 and keeps a Buy rating on the shares after the company announced an agreement to acquire Nova Medical Centers for $265M, pre-announced Q4 results, and provided 2025 guide that was roughly in line with consensus excluding the Nova deal contribution. The firm raised its estimates for a better Q4 and the deal and raised its multiple given the increased visibility into estimates.
B of A Securities
Joanna Gajuk
Hold
to
Strong Buy
Upgrades
$24
2024-12-16
Reason
B of A Securities
Joanna Gajuk
Price Target
$24
2024-12-16
Upgrades
Hold
to
Strong Buy
Reason
RBC Capital
Ben Hendrix
Buy
Maintains
$33 → $30
2024-11-04
Reason
RBC Capital
Ben Hendrix
Price Target
$33 → $30
2024-11-04
Maintains
Buy
Reason
B of A Securities
Joanna Gajuk
Strong Buy
to
Hold
Downgrades
$31 → $24
2024-10-07
Reason
B of A Securities
Joanna Gajuk
Price Target
$31 → $24
2024-10-07
Downgrades
Strong Buy
to
Hold
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Concentra Group Holdings Parent Inc (CON.N) is 14.05, compared to its 5-year average forward P/E of 17.11. For a more detailed relative valuation and DCF analysis to assess Concentra Group Holdings Parent Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued
5Y Average PE
17.11
Current PE
14.05
Overvalued PE
18.80
Undervalued PE
15.43
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair
5Y Average EV/EBITDA
10.76
Current EV/EBITDA
10.69
Overvalued EV/EBITDA
11.65
Undervalued EV/EBITDA
9.88
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued
5Y Average PS
1.35
Current PS
1.15
Overvalued PS
1.45
Undervalued PS
1.24
Financials
Annual
Quarterly
FY2025Q1
YoY :
+7.09%
500.75M
Total Revenue
FY2025Q1
YoY :
+4.05%
80.63M
Operating Profit
FY2025Q1
YoY :
-19.17%
40.64M
Net Income after Tax
FY2025Q1
YoY :
-23.08%
0.30
EPS - Diluted
FY2025Q1
YoY :
-114.72%
-4.03M
Free Cash Flow
FY2025Q1
YoY :
+5.80%
25.37
Gross Profit Margin - %
FY2025Q1
YoY :
-9.49%
9.25
FCF Margin - %
FY2025Q1
YoY :
-24.47%
8.12
Net Margin - %
FY2025Q1
12.00
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
2.0M
Volume
2
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
4
3.5M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
CON News & Events
Events Timeline
2025-06-02 (ET)
2025-06-02
09:21:19
Concentra announces closing of Pivot Onsite Innovations acquisition

2025-05-19 (ET)
2025-05-19
09:09:11
Concentra expands in Chattanooga, Tennessee with new medical center

2025-05-07 (ET)
2025-05-07
16:31:59
Concentra sees FY25 revenue $2.1B-$2.15B, consensus $2.1B

Sign Up For More Events
Sign Up For More Events
News
8.5
07-21NASDAQ.COMConcentra To Acquire ITeos
8.0
07-17NASDAQ.COMInteresting CON Call Options For March 2026
9.5
07-07NewsfilterConcentra® to Announce Second Quarter 2025 Results on Thursday, August 7, 2025
Sign Up For More News
People Also Watch

STNG
Scorpio Tankers Inc
44.090
USD
-1.23%

PSMT
PriceSmart Inc
107.190
USD
+2.45%

FFBC
First Financial Bancorp
24.860
USD
+4.28%

YELP
Yelp Inc
34.700
USD
-1.06%

TBBK
Bancorp Inc
63.665
USD
-8.55%

BHC
Bausch Health Companies Inc
6.770
USD
-0.15%

GT
Goodyear Tire & Rubber Co
10.910
USD
-3.28%

PRVA
Privia Health Group Inc
19.705
USD
+0.03%

MCY
Mercury General Corp
69.650
USD
+0.48%

HUT
Hut 8 Corp
20.380
USD
-3.60%
FAQ

What is Concentra Group Holdings Parent Inc (CON) stock price today?
The current price of CON is 19.66 USD — it has increased 0.1 % in the last trading day.

What is Concentra Group Holdings Parent Inc (CON)'s business?

What is the price predicton of CON Stock?

What is Concentra Group Holdings Parent Inc (CON)'s revenue for the last quarter?

What is Concentra Group Holdings Parent Inc (CON)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Concentra Group Holdings Parent Inc (CON)'s fundamentals?

How many employees does Concentra Group Holdings Parent Inc (CON). have?
